Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. | Cancers (Basel) | 2021 | 34201346 | PubTator, text mining | PubMed |
| DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). | Genes (Basel) | 2021 | 34200630 | PubTator, text mining | PubMed |
| Mutagenic Consequences of Sublethal Cell Death Signaling. | Int J Mol Sci | 2021 | 34200309 | PubTator, text mining | PubMed |
| MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers. | Heliyon | 2021 | 34195444 | PubTator, text mining | PubMed |
| Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis. | Front Cardiovasc Med | 2021 | 34195238 | PubTator, text mining | PubMed |
| Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation. | Leuk Res Rep | 2021 | 34194969 | PubTator, text mining | PubMed |
| Dicentric (7;12)(p11;p11) in T/Myeloid Mixed-Phenotype Acute Leukemia | Turk J Haematol | 2021 | 34190688 | PubTator, text mining | PubMed |
| Low-dose decitabine plus venetoclax is safe and effective as post-transplant maintenance therapy for high-risk acute myeloid leukemia and myelodysplastic syndrome. | Cancer Sci | 2021 | 34185931 | PubTator, text mining | PubMed |
| Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML. | Front Oncol | 2021 | 34178663 | PubTator, text mining | PubMed |
| MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway. | EBioMedicine | 2021 | 34166980 | PubTator, text mining | PubMed |
| Analysis of exosome-derived microRNAs reveals insights of intercellular communication during invasion of breast, prostate and glioblastoma cancer cells. | Cell Adh Migr | 2021 | 34157951 | PubTator, text mining | PubMed |
| RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner. | Leukemia | 2021 | 34148054 | PubTator, text mining | PubMed |
| Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature. | Front Immunol | 2021 | 34135913 | PubTator, text mining | PubMed |
| Core binding factor acute myelogenous leukemia-2021 treatment algorithm. | Blood Cancer J | 2021 | 34135311 | PubTator, text mining | PubMed |
| Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. | Blood Cancer J | 2021 | 34135310 | PubTator, text mining | PubMed |
| A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA. | Leukemia | 2021 | 34131282 | PubTator, text mining | PubMed |
| Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts. | Br J Haematol | 2021 | 34120331 | PubTator, text mining | PubMed |
| Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. | Nat Rev Drug Discov | 2021 | 34117457 | PubTator, text mining | PubMed |
Incidental identification of inv(16)(p13.1q22)/CBFB-MYH11 variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy. | Cold Spring Harb Mol Case Stud | 2021 | 34117074 | PubTator, text mining | PubMed |
| Physio-pathological effects of m6A modification and its potential contribution to melanoma. | Clin Transl Oncol | 2021 | 34105069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=58